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ABSTRACT: This study aims to develop a new evaluation method for quickly and conveniently screening
cognitive impairment in the elderly. The five-minute cognitive test (FCT) was designed to capture deficits in five
domains of cognitive abilities, including episodic memory, language fluency, time orientation, visuospatial
function, and executive function. Subsequently, FCT efficiencies in differentiating normally cognitive ability from
cognitive impairment were explored and compared with that of the Mini-Mental Status Evaluation (MMSE).
Equipercentile equating method was utilized to create a crosswalk between scores of the FCT and MMSE.
Further, the association of scores of the FCT and MMSE with hippocampal volumes was investigated. There were
241 subjects aged 60 years or above enrolled in this study, including 107 adults with cognitive abilities in normal
range, 107 patients with mild cognitive impairment (MCI), and 27 patients with mild Alzheimer disease (AD).
The AUC of FCT for detection of cognitive impairment (MCI and mild AD) was 0.885 (95% CI 0.838 to 0.922).
The sensitivity and specificity of FCT for the diagnosis of cognitive impairment were 80.6% and 84.11 %,
respectively. FCT’s diagnostic performance was superior to that of MMSE in the same cohort. Mean completion
time of FCT was 339.9 ± 67.7 seconds (5-6 min). In addition, a conversion table between scores on the FCT and
MMSE was created. Further, the FCT scores were positively correlated with hippocampal volumes. The FCT is
a novel, reliable, and valid cognitive screening test for the detection of dementia at early stages.

Key words: mild cognitive impairment, Alzheimer’s disease, brief cognitive test, equipercentile equating method

As old population is dramatically growing, the detection
of early cognitive deficit will become increasingly crucial.
Effective cognitive screening test with quick and
convenient merits will ensure recognition of early
cognitive deficit and timely intervention [1, 2]. Cognitive
screening test should have good sensitivity and specificity
for detecting cognitive impairment at the early stage,
including mild cognitive impairment (MCI) and mild
dementia [3]. Given time pressure in clinical practice or

large-scale epidemiological studies, it would be more
preferable if a cognitive screening tool can be completed
in the minimum time possible. Despite the existence of
numerous cognitive screening tools, several limitations
need to be remedied [1, 2, 4], including low accuracy for
diagnosing mild cognitive deficit [5-7] or a long time
consumption [8-10]. Thus, the tradeoff between statistical
robustness and administration time should be carefully
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weighted when novel cognitive screening tool is
developed.
According to Jeremy Brown, short cognitive tests can
be further categorized into three groups: (1) Short
questionnaires, (2) Highly selective tests, and (3) Multidomain tests [11]. Although short questionnaires or highly
selective tests may take less than 5 minutes to administrate
[11, 12], multi-domain tests are the most useful tools for
capturing deficits in a variety of cognitive domains, but
typically at the cost of long administration time (usually >
10 minutes) [11]. Many screening tools are currently
available but no tools meet the four important

Five-minute Cognitive Test

requirements for widespread use in clinical practice or
large-scale epidemiological studies — that is, capture a
clinically acceptable range of cognitive domains, take
short time to administrate (around 5 minutes), have high
accuracy for detecting cognitive impairment, and
incorporate visual recall, which is the earliest deficits in
Alzheimer’s disease (AD) patients [13]. In the present
study, we developed a novel cognitive screening tool,
Five-minute cognitive test (FCT), to achieve these
required qualities.

Figure 1. Instruction page of Five-minute Cognitive test.
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selected from the International Picture Naming Project as
test items of episodic memory. The FCT scores range
from 0 to 20 and lower scores reflect worse cognitive
performance.
Subjects
There were 360 subjects aged 60 years or above enrolled
in this study, including 226 individuals with cognitive
abilities in normal range, 107 patients with MCI and 27
patients with mild AD. Written informed consents were
obtained from all participants or authorized
representatives.

Figure 2. Picture page of Five-minute Cognitive test.

First, we compared the diagnostic performance of FCT
and Mini-Mental State Examination (MMSE) for
discriminating cognitive ability in normal range from
mild cognitive decline. Second, equipercentile equating
method was utilized to create a crosswalk between scores
of the FCT and MMSE. Third, the relationships between
the FCT scores and other neuropsychological assessments
were examined. Finally, we investigated the association
of the FCT scores with hippocampal volumes in nondemented individuals.
MATERIALS AND METHODS
The study was approved by the Committee on Medical
Ethics of Zhongshan Hospital, Fudan University.
FCT design
The FCT was developed in a multiphase study and the
final version was established to evaluate five cognitive
domains, including episodic memory, language fluency,
time orientation, visuospatial function, and executive
function (Fig. 1-3). Eight culturally neutral pictures were

Figure 3. The FCT test.

All subjects had abilities of intact understanding and
fluent expression in Mandarin Chinese and received 6
years or more of education. Subjects with any severe
neurological diseases but AD and MCI were excluded.
The cognitive ability in normal range was defined as
subjects having total 24 scores or above assayed by
MMSE [5] and 0 score of Clinical Dementia Rating
(CDR)[14]. MCI patients had a score of 24 or higher on
the MMSE, a score of 0 or 0.5 on CDR, a subjective
cognitive complaint, objective cognitive impairment as
examined by a comprehensive battery of neuropsychological assessments, essentially preserved
activities of daily living, and were not demented [3, 15].
The mild AD group met the National Institute of
Neurological and Communicative Disorders and Stroke
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and AD and Related Disorders Association criteria for
probable AD [16] and had a score of 0.5 or 1 on the CDR.
Neuropsychological and clinical assessments
Participants received a battery of cognitive and clinical
assessments, including FCT, MMSE [5], Auditory Verbal
Learning Test (AVLT)[17], Rey-Osterrieth Complex
Figure Test (CFT)[18], Boston Naming Test (BNT-30),
Animal Fluency Test (AFT)[19], Trail Making Test A and
B (TMT-A, TMT -B)[20], Symbol Digit Modalities Test
(SDMT)[21], CDR, Activities of Daily Living scale
(ADL), Geriatric Depression Scale (GDS-15)[22]. Each
participant with MCI or mild AD received a CT/MRI
scanning.
MRI data acquisition
The data of high-resolution structural MRI were acquired
from a 3.0 Tesla Siemens Verio MRI scanner. Participants
were scanned using a three-dimensional T1-weighted
MPRAGE sequence at the Department of Radiology,
Zhongshan Hospital, Fudan University. MRI series
included T1-weighted 3D fast, spoiled gradient recalled

echo images and other sequences such as T2-weighted
and FLAIR images to visualize focal lesions of cortical or
white matter. The scanning parameters were as follows:
TR/TE: 1900/2.5 ms, flip angle: 9◦, slice thickness 1 mm,
176 contiguous sagittal slices, field of view 256 mm,
voxel resolution 1 × 1 × 1 mm, 8-channels head receiver
coil. Each 3-D T1-weighted MPRAGE sequence scan
lasted for 4 min and 18 sec. All subjects were righthanded.
Hippocampal volumes
CAT12 toolbox (C. Gaser, Structural Brain Mapping
group, Jena University Hospital, Jena, Germany)
implemented in SPM12 (www.fil.ion.ucl.ac.uk) were
utilized to perform the voxel-based morphometry (VBM)
analysis. The morphometric analysis by regions of interest
(ROIs) was applied to extract the data of hippocampal
volume. The methods have been described previously [23,
24] and can be found at the CAT12 website
(www.neuro.uni-jena.de/cat12/CAT12-Manual.pdf).

Table 1. Demographics and clinical characteristics according to diagnosis.
Characteristics
Age, years

CN
(n =107)
69.6 ±5.4

MCI
(n = 107)
69.7 ±5.7

Mild AD
(n = 27)
72 ±7.9

Male/Female, n
Education, years
CDR
ADL
MMSE
FCT
AVLT- delayed recall
Animal fluency
BNT-30
TMT-A
TMT-B
CFT
SDMT

40/67
11.7 ±2.8
0 ±0.05
20.2 ±0.4
27.9 ±1.28
17.8 ±1.2
5.94 ±2.05
16.7 ±3.63
24.2 ±3.28
56.1 ±13.1
153 ±44
30.3 ±2.92
37.9 ±7.62

39/68
11.4 ±2.9
0.36 ±0.22 #
20.8 ±0.8 #
26.3 ±1.9 #
14.9 ±2.8 #
2.91 ±2.08
13.9 ±3.71
21.7 ±3.76
72.2 ±25.4
201 ±59.3
26.4 ±4.72
30.9 ±9.33

10/17
9.9 ±4.14 $
0.96 ±0.1 $, &
24.6 ±2.9 $, &
20.1 ±2.9 $, &
8 ±3.2 $, &
/
/
/
/
/
/
/

P value
0.149
0.99
0.02
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

Abbreviations: CN: Cognitively normal; MCI: Mild cognitive impairment; AD: Alzheimer’s disease; CDR: Clinical dementia rating
scale; ADL: Activities of Daily Living scale; MMSE: Mini-mental state examination; FCT: Five-minute cognitive test. AVLT:
Auditory Verbal Learning Test; BNT-30: Boston Naming Test-30; TMT-A: Trail Making Test A; TMT-B: Trail Making Test B; CFT:
Rey-Osterrieth Complex Figure Test; SDMT: Symbol Digit Modalities Test.
# that is marked behind “MCI group” represents p < 0.05 when the data from CN group and MCI group were compared.
$ that is marked behind “AD group” represents p < 0.05 when the data from CN group and AD group were compared.
& that is marked behind “AD group” represents p < 0.05 when the data from MCI group and AD group were compared.
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Figure 4. FCT and MMSE scores in three diagnostic groups. Abbreviations: CN: Cognitively normal; MCI: Mild
cognitive impairment; AD: Alzheimer’s disease; MMSE: Mini-mental state examination; FCT: Five-minute
cognitive test.

Statistical analysis
The differences in continuous variables between groups
were identified using the F-test. The Pearson x2 test was
used to compare the distributions of categorical variables
among healthy controls, patients with MCI and mild AD.
Diagnostic performance was examined using the area
under the curve (AUC), sensitivity, and specificity. The
Intraclass Correlation Coefficient (ICC) was utilized to
assess the inter-rater and test-retest reliability.
Additionally, FCT scores were equated to MMSE scores
using the equipercentile equating method [25, 26], which
has been applied to equate a variety of standardized
tests[27-29]. All data analyses were conducted with R
statistical software (R version 3.3.3). The level of
statistical significance was set at p < 0.05.
RESULTS
Demographic and clinical information

Initially, there was a total of 360 subjects, including 226
subjects with normal cognition, 107 subjects with MCI
and 27 patients with mild AD. However, we found that
controls have significantly higher education than subjects
with MCI (12 ± 2.9 vs 11.4 ± 2.9; p < 0.001). It is well
known that education is a factor that affects the scores of
the cognitive assessments. Thus, we applied propensity
score matching (PSM) to minimize confounding biases
[30, 31]. Through PSM with ratio of 1 to 1 (Controls:
MCIs), a total of 107 healthy controls were selected from
the initial 226 healthy controls. The demographic and
clinical data of 241 participants were listed in Table 1.
Relationship between FCT scores and demographics
The FCT scores were significantly correlated with age (r
= -0.21, p < 0.001) and educational year (r = 0.23, p <
0.001) in the whole sample. There was no significant
difference in FCT score between males and females (p >
0.05).
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Figure 5. ROC analysis of FCT and MMSE. Abbreviations: CN: Cognitively normal; MCI: Mild cognitive impairment; AD:
Alzheimer’s disease; CI: Cognitively impaired; MMSE: Mini-mental state examination; FCT: Five-minute cognitive test.

The completion time of FCT

Diagnostic performance of FCT and MMSE

The average administration time was 313.3 ± 41.6 s in
individuals with cognitive abilities in normal range, 360 ±
61.7 s in patients with MCI, 466.5 ±96.4 s in patients with
mild AD, respectively.

For discriminating CN from MCI (Fig. 5A), the AUC of
FCT was 0.856 (0.802 – 0.900) with sensitivity of 75.7 %
(66.5 % to 83.5 %) and specificity of 84.11 % (75.8% to
90.5 %) when the cut-off point was set to 16.5. The AUC
of MMSE was 0.758 (0.695 – 0.814) with sensitivity of
74.8 % (65.4 % to 82.7 %) and specificity of 63.6 % (53.7
% to 72.6 %) when the cut-off point was set to 27.
For discriminating between CN and AD (Fig. 5B), the
AUC of FCT was 1 (0.972 – 1) with sensitivity of 100 %
(87.2 % to 100 %) and specificity of 98.13 % (93.4% to
99.8% when the cut-off point was set to 14.5. The AUC
of MMSE was 0.998 (0.969 – 1) with sensitivity of 100 %
(87.2 % to 100 %) and specificity of 98.13 % (93.4 % to
99.8 %) when the cut-off point was set to 24.

FCT and MMSE scores in three diagnostic groups
As shown in Table 1 and Figure 4, the average FCT scores
were 17.8 ± 1.2 in normal controls, 14.9 ± 2.8 in patients
with MCI, and 8 ± 3.2 in patients with mild AD,
respectively. The average MMSE scores were 27.9 ±1.28
in normal controls, 26.3 ± 1.9 in patients with MCI, and
20.1 ±2.9 in patients with mild AD, respectively.
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Table 2. Equivalent MMSE scores are shown for possible scores on the FCT.
FCT

Equivalent
MMSE

FCT

Equivalent
MMSE

FCT

Equivalent
MMSE

FCT

Equivalent
MMSE

0

10

5.5

18

11

23

16.5

27

0.5
1

10
11

6
6.5

19
20

11.5
12

24
24

17
17.5

27
28

1.5

12

7

21

12.5

24

18

28

2

12

7.5

21

13

24

18.5

29

2.5

13

8

22

13.5

25

19

29

3

14

8.5

22

14

25

19.5

30

3.5

15

9

22

14.5

25

20

30

4

16

9.5

23

15

26

4.5

17

10

23

15.5

26

5

17

10.5

23

16

26

Abbreviations: MMSE: Mini-mental state examination; FCT: Five-minute cognitive test.

For discriminating MCI from AD (Figure 5.C), the
AUC of FCT was 0.942 (0.888 – 0.975) with sensitivity
of 96.3 % (81 % to 99.9 %) and specificity 82.24 %
(73.7% to 89 %) when the cut-off point was set to 12.5.
The AUC of MMSE was 0.97 (0.925 – 0.992) with a
sensitivity of 100 % (87.2 % to 100 %) and specificity
83.2 % (74.7 % to 89.7 %) when the cut-off point was set
to 24.
For discriminating between CN and CI (MCI + AD;
Figure 5.D), the AUC of FCT was 0.885 (0.838 – 0.922)
with sensitivity of 80.6 % (72.9 % to 86.9 %) and
specificity of 84.11 % (75.8 % to 90.5 %) when the cutoff point was set to 16.5. The AUC of MMSE was 0.806
(0.751 – 0.854) with sensitivity of 59.7 % (50.9 % to 68.1
%) and specificity of 85.1 % (76.9 % to 91.2 %) when the
cut-off point was set to 26.

The equipercentile equating analysis was utilized and
equivalent MMSE scores were shown for possible scores
of the FCT (Table 2). In addition, a plot of the
equipercentile equivalent scores on FCT and MMSE is
demonstrated in Figure 6. For instance, a score of 12.5 on
the FCT is equivalent to a score of 24 on the MMSE.

Inter-rater and test-retest reliability
To evaluate the inter-rater reliability of FCT, the data
were collected twice from a subsample of 22 (CN and
MCI) by two raters (Zhang and Wang). The average
interval was 48.7 ± 20.9 days. Intraclass correlation
coefficient (ICC) is 0.91, indicating an excellent interrater reliability. Regarding the test-rest reliability, the data
were collected twice from another subsample of 16 (CN
and MCI) by the same rater (Zhang). The average interval
was 64.7±17.7 days. ICC is 0.86, indicating a good testretest reliability.
Crosswalk between corresponding scores of the FCT
and MMSE

Figure 6. A plot of the equipercentile equivalent scores on the
MMSE and FCT. Abbreviations: MMSE: Mini-mental state
examination; FCT: Five-minute cognitive test.

Correlations between the FCT scores and other
neuropsychological assessments
In these correlational analyses, there was a total of 333
non-demented individuals (226 individuals with normal
cognition and 107 individuals with MCI). Spearman’s
correlation analyses were utilized to examine the
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relationships between the FCT scores and other
neuropsychological assessments (Figure 7). The FCT
scores were positively associated with AVLT delay recall
(rho = 0.46, p < 0.001), animal fluency (rho = 0.33, p <
0.001), BNT-30 (rho = 0.38, p < 0.001), CFT (0.32, p <

Five-minute Cognitive Test

0.001) and SDMT (rho = 0.36, p < 0.001) scores. Further,
the FCT scores were negatively associated with TMT-A
(rho = -0.33, p < 0.001) and TMT-B (rho = -0.38, p <
0.001) scores.

Figure 7. Correlations between the FCT scores and other cognitive domains. Abbreviation: FCT: Five-minute cognitive
test. AVLT: Auditory Verbal Learning Test; BNT-30: Boston Naming Test-30; TMT-A: Trail Making Test A; TMT-B:
Trail Making Test B; CFT: Rey-Osterrieth Complex Figure Test; SDMT: Symbol Digit Modalities Test.

Correlations of the FCT and MMSE scores with
hippocampal volumes in non-demented elderly
In a subsample of 62 non-demented elderly (including 32
individuals with cognitive abilities in normal range and 30
individuals with MCI) with hippocampal volume data, the
correlations of the FCT and MMSE scores with
hippocampal volumes were evaluated using the cocor
package [32]. The results showed that both FCT (rho =
0.406, p = 0.0005) and MMSE (rho = 0.346, p = 0.008)
scores were positively correlated with hippocampal
volumes while there was no significant difference in the
magnitude of two correlations (p > 0.05; Fig. 8).

DISCUSSION
In this study, we developed a new cognitive screening test
that can quickly and accurately identify cognitive deficits.
The average administration time of FCT was found to be
339.9 ±67.7 s (5-6 min) in the whole sample. The validity
of FCT for discriminating subjects with cognitive abilities
in normal range from mild cognitive impairment (MCI
and mild AD) was found to be clinically acceptable and
superior to MMSE in sensitivity (80.6% vs 59.7%),
specificity (84.11 % vs 85.1%), and AUC (0.885 vs
0.806). In addition, equipercentile equating method was
used to create a conversion table, which enables easy and
direct comparison of scores on FCT and MMSE.
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Figure 8. Correlations of FCT and MMSE scores with Hippocampal volumes in non-demented elderly. Abbreviations:
MMSE: Mini-mental state examination; FCT: Five-minute cognitive test.

The FCT was designed to capture deficits in a broad range
of cognitive domains, including episodic memory,
language fluency, time orientation, visuospatial function,
and executive function. Episodic memory deficits have
been found to predict progression to AD among subjects
with MCI [33]. Therefore, the greater emphasis on
episodic memory places the FCT at an advantage over the
other existing cognitive screening tests for the early
detection of AD, the most common type of dementia [34].
In addition, compared to MMSE, the FCT includes more
robust measures of executive and visuospatial function,
which may contribute to the reduction of practice and
ceiling effects.
Table 3. Demographic and clinical information of 62 nondemented elderly.
Variables

Overall sample (n = 62)

Age, y

69.4 ±5.6

Female gender, n (%)

45 (72.6)

Education, y

12 ±2.8

FCT

16.7 ±2.5

MMSE

27.3 ±1.9

Hippocampal volume, ml

7.5 ±0.9

Abbreviations: MMSE: Mini-mental state examination; FCT: Fiveminute cognitive test.

Because the MMSE has been extensively used in the
cognitive assessment of older people in both clinical
research and practice, conversion scores between FCT
and MMSE will facilitate the adoption of the FCT. The
linkage between FCT scores to MMSE scores is helpful
to interpret individual performance and thus facilitate use
of this new cognitive screening test. Our study showed
that there is a good crosswalk between corresponding
scores of the FCT and MMSE. For example, an FCT score
of 12.5 is equivalent to a MMSE score of 24 (Fig. 6).
Finally, to examine whether the FCT scores are
sensitive to changes in AD-related brain region,
Spearman’s correlation test was conducted to investigate
the association of the FCT scores with hippocampal
volumes in non-demented elderly. Our data found a
positive correlation between the FCT scores and
hippocampal volumes (r = 0.406, p = 0.0005), which play
an important role in episodic memory [35-37] and also
correlates to MCI [38] and AD dementia [39]. This may
be explained by the fact that the FCT was designed with a
heavy emphasis on episodic memory (8 out of 20 points).
Further, previous studies reported a specific memory
profile in AD patients, which is characterized by a
diminished free recall ability that is only marginally
ameliorated by cueing [40, 41]. These neuropsychological
findings have also been integrated into the development
of the FCT. The cued recall technique, utilized in the FCT,
can isolate the amnesic syndrome of the medial temporal
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type [41, 42]. In future studies, it would be very important
to determine the exact value of the FCT scores in
combination with hippocampal volumes for predicting
cognitive decline and conversion from MCI to AD
dementia.
The current study has several important clinical
implications. First, given the growing prevalence of
cognitive impairment, rapid, efficient, and valid cognitive
screening tests are essential. However, most of the
existing brief cognitive tests were designed for use in
western developed countries and therefore pose
application problems when applied in Chinese people
[43]. Translation into Chinese may help alleviate this
issue, although the translation process often contributes to
the alterations of the original neuropsychological
properties. Thus, brief cognitive tests that transcend
language and cultural barriers are needed. In an effort to
circumvent the need to translate to other languages, items
of FCT were designed to be as culture-neutral as possible.
Second, previous studies found that a picture-based
memory test can discriminate between normal controls
and patients with AD and predict progression from MCI
to AD with high sensitivity and specificity [33, 40]. These
neuropsychological findings should be integrated into the
development of novel screening tools. Thus, for the FCT,
the recall of pictures rather than words was used to capture
deficit in episodic memory. This design may hopefully
facilitate the adoption of the FCT in other non-Chinese
speaking countries. Finally, most of popular screening
tools take ten minutes or more to complete [5, 8]. The
cognitive screening tests with shorter administration time
would be more desirable when used in the doctor’s office
or large-scale epidemiological studies.
There are several limitations that should be
addressed. First, in this study, participants were eligible if
they had 6 years or more of education. This limits our
ability to generalize our findings to other population with
less educational levels. This limitation should be
remedied in further studies. Second, because the items of
episodic memory were pictured-based, the FCT cannot be
administered to subjects with severe visual impairment.
The braille version of FCT should be developed in the
future. Third, the sample size of the AD group is relatively
small. Further studies with larger sample size of AD
patients are warranted.
In conclusion, the FCT provides an alternative
instrument and is superior to MMSE in discriminating
normal cognitive abilities from mild cognitive
impairment. Further, there is a good crosswalk between
FCT and MMSE scores using equipercentile equating as
well as positive correlation between FCT scores and
hippocampal volume. These findings may facilitate the
adoption of FCT in clinical research and practice.

Five-minute Cognitive Test
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